Inside Abridge: The AI Listening to 100 Million Doctor Visits — Abridge's Janie Lee & Chai Asawa
Summary
Abridge is using ambient documentation as the wedge into a broader clinical-intelligence layer built around the doctor-patient conversation. Clinicians spend 10–20 hours a week documenting care, while nearly everything within healthcare’s roughly 20% share of GDP—from diagnoses and treatment to claims and payment—derives from that conversation. With close to 100 million medical conversations, Abridge sees the resulting traces as both product context and proprietary-data “exhaust.”
The commercial roadmap moves from saving clinicians time to helping health systems save money, make money, and ultimately improve outcomes. Documentation reduces “pajama time,” with clinicians reporting that they can eat dinner with their children, that Abridge helped them retire early, or even saying, “we’re not divorcing anymore.” But CFOs require dollar-denominated ROI from more compliant notes, fewer billing queries, and improved revenue—not merely happier doctors.
Prior authorization is the sharpest example of AI compressing healthcare latency from weeks or months into minutes. For an MRI, Abridge could confirm four of six Aetna-plan criteria from the patient record, then prompt the doctor—before the patient leaves—to confirm physical therapy and pain lasting more than six weeks. The opportunity is to replace a process that can take 45 days and perhaps 20 touchpoints with one clinically timed interaction.
The moat is the combination of context, workflow position, integrations, and reliability—not a generic model wrapper. Real-time decisions may require EHR history, labs, imaging, payer identity, state-specific policies, and unstructured 50-page PDFs; meanwhile, Jenny estimates that over 90% of conventional healthcare alerts are ignored. Abridge wants the product to feel like “air conditioning”: quietly improving the encounter and intervening only when acting now materially changes care.
Abridge mixes proprietary and third-party models according to quality, latency, and cost, with scale changing the optimization frontier. Its proprietary conversation data can improve transcription, diarization, notes, personalization, and specialized agents, while third-party providers may supply increasingly strong general medical knowledge and agentic capabilities. Chai’s architecture is a “constellation of models,” including fast triage models that can hand work to larger ones.
Healthcare-grade evaluation and controlled deployment are core assets because “80/20 doesn’t work here.” Abridge calibrates specialty- and domain-specific judges, uses clinicians and coding teams, progressively rolls out changes, and has moved customer release cycles from quarterly or twice yearly toward monthly—with some health systems co-developing earlier. Patient data used for learning is de-identified one way, while access and retention of identifiable information remain contractually constrained.
The strategic upside is a shared intelligence platform serving clinicians, patients, payers, and pharma without handing payers raw encounter data. The same conversation can generate documentation, explain next steps to patients, support payment decisions, or identify possible clinical-trial candidates. Deep EHR interoperability remains table stakes, but Abridge’s intended territory extends beyond the record system into intelligence connecting healthcare’s major stakeholders.
The guests reject two easy assumptions: that healthcare will see AI innovation last and that prototypes make written product judgment obsolete. Chai now expects some of the hardest AI work to happen in healthcare first because zero-error evaluation and low-tolerance workflows are mandatory; Jenny argues that “crisp written clarity is more important than ever” when every launch touches large systems, compliance, implementation, and scarce organizational attention. The operating maxim is “go slow to go fast.”
Deep dive
Not yet available upstream; scheduled sync will retry.